Pathogenesis and Etiology of Functional Impairment
Impairments in thrombocytopathies develop at a deep cellular level. The pathogenesis is based on the following key mechanisms:
- Defects and structural anomalies of the platelet cell membrane.
- Profound disorders of intracellular metabolism of key substances: calcium, serotonin, and adenine nucleotides.
- Marked deficiency of specific proteins, primarily von Willebrand factor and thrombin-sensitive proteins.
Among the causes (etiology) triggering acquired forms of thrombocytopathies are:
- Various protein metabolism disorders.
- Acute or chronic vitamin C deficiency.
- Hormonal imbalances and disorders.
- Negative impact of medications, toxic substances, and radiation factors.
- Consequences of massive blood transfusions.
Thrombocytosis: Classification and Causes
In contrast to functional impairment, thrombocytosis is a pathological increase in the absolute platelet count in peripheral blood. Globally, all types of thrombocytosis are divided into two major categories:
- Reactive thrombocytosis. This is always exclusively temporary in nature. The causes of its development include:
- Splenectomy (surgical removal of the spleen).
- Acute blood loss or conditions of acute hemolysis.
- Early and late postoperative periods.
- Presence of malignant neoplasms.
- Severe inflammatory and infectious processes: tuberculosis, osteomyelitis.
- Autoimmune and systemic pathologies: rheumatoid arthritis, ulcerative colitis.
- Neoplastic thrombocytosis. This is a consequence of malignant cell transformation. It occurs in myeloid leukemias and various myeloproliferative disorders.
The Thrombocytosis Paradox: From Thrombi to Bleeding
The clinical presentation of thrombocytosis is paradoxical in nature. A large mass of circulating platelets initially provokes severe microcirculatory pathology, causing massive blood clotting.
However, this process leads to the rapid depletion of plasma clotting factors, resulting in the subsequent development of hemorrhagic syndrome (bleeding).
The extreme degree of this pathological cascade is hemorrhagic thrombocythemia. This is a specific state of hyperthrombocytosis in which the platelet count exceeds 1 million, which is inevitably accompanied by severe hemorrhagic syndrome.
Thrombophilia (Thrombotic Disease)
Thrombophilia is a specific condition of the organism characterized by a pathologically increased propensity for intravascular blood coagulation, i.e., thrombus formation.
The pathogenesis is based on the influence of various external and internal environmental factors. These triggers induce excessive thrombinogenesis, ultimately causing the formation of thrombosis. Further classification of this condition is based on its origin.
Briefly: answers to topical questions
Which hereditary diseases are classified as thrombocytopathies?
Hereditary thrombocytopathies comprise an extensive group of genetically determined diseases. The main forms include:
- Chédiak–Higashi syndrome — dysfunction caused by impaired platelet structure.
- von Willebrand disease — combined defect with factor VIII:C deficiency.
- Bernard–Soulier syndrome — glycoprotein deficiency and giant megakaryocyte and platelet anomalies.
- Wiskott–Aldrich syndrome — presence of a large number of platelet microforms.
- Fanconi syndrome — hematopoietic stem cell defect.
- Glanzmann thrombasthenia — absence of the glycoprotein IIb/IIIa complex on the plasma membrane.
- Hereditary afibrinogenemia — fibrinogen deficiency or integrin defect.
Also distinguished are gray platelet syndrome, Quebec platelet disorder, ARC syndrome, Paris–Trousseau syndrome, Hermansky–Pudlak syndrome, and TAR syndrome.
How are thrombocytopathies classified depending on the impaired platelet function?
Depending on the impaired stage of platelet hemostasis, hereditary thrombocytopathies are classified into four main groups.
- Adhesion pathologies — impaired attachment to the subendothelium due to a receptor apparatus defect or binding protein defect (Bernard–Soulier syndrome, von Willebrand disease).
- Aggregation pathologies — impaired platelet-to-platelet clumping (Glanzmann thrombasthenia, hereditary afibrinogenemia).
- Degranulation disorders — storage pool deficiency associated with the absence of specific granules or impaired release of their contents (α-granule deficiency, dense δ-granule deficiency, or combined deficiency).
- Signaling pathway and platelet formation defects — intracellular signal transduction impairments at the receptor level and structural anomalies.
What types of bleeding and clinical manifestations are typical for thrombocytopathies?
Thrombocytopathies are characterized by a petechial-purpuric (microcirculatory) type of bleeding. Clinical manifestations include:
- Cutaneous hemorrhages — painless asymmetric bruises, small hemorrhages (petechiae), and ecchymoses.
- Mucosal bleeding — recurrent spontaneous or trauma-disproportionate mucocutaneous bleeding, gastrointestinal bleeding.
- Menorrhagia — heavy menstrual bleeding in women.
- Post-traumatic hemorrhages — bleeding occurs immediately after trauma or surgical intervention.
The platelet count in thrombocytopathies often remains normal, but qualitative platelet defects may be combined with thrombocytopenia in certain cases.
To avoid confusing the terms: thrombocytoPATHY — cells are "sick" (dysfunctional, but their count is normal), thrombocytoSIS — too many cells, thrombocytoPENIA — too few cells.
Class and exam questions
Is the platelet count always decreased in thrombocytopathy?
No, the platelet count typically remains normal. The main issue lies in their functional deficiency rather than a quantitative deficit.
Why does thrombocytosis (excess of platelets) lead to bleeding?
A massive mass of platelets causes microthromboses, which rapidly consume clotting factors. Their depletion leads to the development of a paradoxical hemorrhagic syndrome.
What morphological changes of platelets are visible under a microscope in thrombocytopathies?
The pathology is characterized by anisocytosis (the presence of cells of varying sizes) and the appearance of specific abnormal forms, such as "gray platelets".
What else to study on this topic
- Mechanisms of serotonin and calcium metabolism disorders in platelet membranes
- The role of von Willebrand factor in vascular-platelet hemostasis
- Differential diagnosis of reactive and neoplastic thrombocytosis
- Pathogenesis of hemorrhagic thrombocythemia
- Classification of thrombophilia by origin
Master the entire topic in the "Pathological Anatomy" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Thrombocytopathies" and 4,414 more pages on the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 153 video lessons on the subject
Other topics in Hematopoietic System Diseases
Free video lessons: pathological anatomyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.